Key facts
- This page summarizes Daphne Quimi's Form 4 filing for AMICUS THERAPEUTICS, INC. (FOLD).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Jan 2023, 18:13.
Daphne Quimi - 02 Jan 2023 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- FOLD
- Reported as of
- 02 Jan 2023
- Net transaction value
- -$287,464
- SEC form
- 4
- Accepted by SEC
- 04 Jan 2023, 18:13:21 UTC
- Prior SEC filing
- 03 Oct 2022
- Next SEC filing
- 06 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christian Formica, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daphne Quimi filed Form 4 for AMICUS THERAPEUTICS, INC. (FOLD) on 04 Jan 2023.
Change
- Previous filing in this sequence was filed on 03 Oct 2022.
- Current net transaction value: -$287,464.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FOLD
transaction
Common Stock
Tax liability
- Transaction value
- $185,165
- Shares
- -15,165
- Change %
- -4.5%
- Price
- $12.21
- Shares after
- 320,147
- Date
- 02 Jan 2023
- Ownership
- Direct
FOLD
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +73,508
- Change %
- +23%
- Price
- $0.000000
- Shares after
- 393,655
- Date
- 03 Jan 2023
- Ownership
- Direct
- Footnotes
- F1
FOLD
transaction
Common Stock
Tax liability
- Transaction value
- $102,300
- Shares
- -8,575
- Change %
- -2.2%
- Price
- $11.93
- Shares after
- 385,080
- Date
- 03 Jan 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FOLD
transaction
Derivative
Stock Options (right to buy)
Award
- Transaction value
- $0
- Shares
- +130,480
- Change %
- Price
- $0.000000
- Shares after
- 130,480
- Date
- 03 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 130,480
- Exercise price
- $11.93
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in four equal annual installments beginning on January 3, 2024 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
Footnote F2
These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.